Composition
- Active ingredients
- CEFOTAXIME SODIUM EQ 1GM BASE/VIAL
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- CEFOTAXIME SODIUM EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · InjectableNDA050547-002 · Discontinued
- CEFOTAXIME SODIUM EQ 2GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · InjectableNDA050547-003 · Discontinued
- CEFOTAXIME SODIUM EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · InjectableNDA050547-001 · Discontinued
- CEFOTAXIME SODIUM EQ 10GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · InjectableNDA050547-004 · Discontinued
- CEFOTAXIME SODIUM EQ 1GM BASE/VIAL · InjectableThis page
- CEFOTAXIME SODIUM EQ 2GM BASE/VIAL · InjectableANDA062659-002 · Discontinued
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA062659.
At a glance
- Brand name
- Claforan
- Active substance
- cefotaxime sodium
- Route
- Injection
- Dosage form
- Injectable
- Applicant
- Sanofi Aventis US
- Status
- Discontinued
- FDA approval
- 13 Jan 1987
- Application
- ANDA062659-001